WithdrawnNCT07043556

Assessment of Artificial Intelligence Algorithms for ROTEM Analysis in Coagulation Management

Sponsor: Ondokuz Mayıs University

Trial Details

Condition	Coagulopathy
Intervention	Artificial Intelligence-Based ROTEM Interpretation
Status	Withdrawn
Est. Completion	5 Jan 2026
Last Updated	2 July 2026

Primary Outcome

treatment

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Adult patients undergoing elective cardiac surgery (CABG, valve surgery, aortic procedures) * Adult patients undergoing liver transplantation * Availability of complete ROTEM results (EXTEM, INTEM, FIBTEM, +/- HEPTEM, APTEM) * Informed written consent obtained Exclusion Criteria: * Incomplete or technically invalid ROTEM data * Pediatric patients (\<18 years) * Refusal to participate or lack of informed consent * Emergency and redo surgeries

Trial Sites

Countries

Turkey (Türkiye)

View Registry Entry

Related Analysis

Withdrawn Trial Spotlight: AI-Driven ROTEM Interpretation vs Expert Panel Consensus in Cardiac and Liver Transplant Coagulopathy — Clinical Implications for Perioperative Practice

A now-withdrawn Turkish clinical trial sought to determine whether large language model AI tools — ChatGPT and Gemini — could match expert clinician interpretation of ROTEM coagulation data in cardiac surgery and liver transplantation. Though no data were collected, the trial raises important questions about AI decision-support in perioperative haemostasis that remain highly relevant to anaesthetists, intensivists, and haematologists worldwide.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service